Gavin Harper, BA

Adelphi Real World, United Kingdom

Disclosure(s): Adelphi Real World: Employee; ViiV Healthcare: Contract for this analysis

Poster(s):

• (P-537) PAIRED - PAtIent Reported Experiences and perceiveD benefit of treatment with dolutegravir/lamivudine (DTG/3TC): a diverse sample of people with HIV-1 reporting high treatment satisfaction, good adherence, and high quality of life
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT